Healthcare as National Defense

Mais episódios de "Dry Powder: The Private Equity Podcast"

• 

  Exit Strategies w/ Thoma Bravo’s Holden Spaht

  há um dia

  11:57

  In part two of our series, Thoma Bravo’s leading enterprise software investor explains how they continue to find exit opportunities and source new deals.
• 

  When the Dam Breaks on Tech Deals w/ Thoma Bravo’s Holden Spaht

  30/04/2024

  22:31

  We ask one of Thoma Bravo’s leading enterprise software investors why 2023 could be a “significantly better” year for deal making.
• 

  Não percas um episódio de “Dry Powder: The Private Equity Podcast” e subscrevê-lo na aplicação GetPodcast.

  
• 

  Data-Driven Impact Investing w/ Bridgespan’s William Foster

  22/04/2024

  17:15

  Private equity firms are developing measures of success that go far beyond carbon footprints.
• 

  Macro Update: Calm, but Not Stable

  04/04/2024

  20:14

  We ask Bain’s leading macro expert about the “last mile” of rate cuts in the US, and whether Europe has miles to go.
• 

  Bain & Company’s 2024 Global Private Equity Report: Executive Summary

  11/03/2024

  19:28

  We seem to have entered a period of eerie calm, but will it last?Read Bain & Company’s 2024 Global Private Equity Report here.View my webinar on March 19th here. 
• 

  The Key to Persistent Performance w/ TPG’s Jim Coulter

  22/02/2024

  20:30

  In part two of our interview, we explore the principles and strategies that enable the industry’s top-performing GP’s to deliver persistent returns.
• 

  Breaking the Tablets w/ TPG’s Jim Coulter

  15/02/2024

  28:06

  A pioneering investor talks to us about challenging the industry’s conventions.
• 

  The Evolution of the Secondaries Market: From Crisis to Opportunity

  23/01/2024

  17:24

  Tom Callahan, CEO of NASDAQ Private Market, argues that today’s liquidity crisis could mark a turning point for secondaries markets.
• 

  The Rise of the Secondaries Market: From Backwater to Boomtown

  16/01/2024

  25:03

  Nigel Dawn, senior managing director at Evercore, explains how GPs and LPs are discovering new tools and techniques to finance deals.
• 

  Inside the Modern Investor Relations Team

  09/01/2024

  19:16

  We asked two of Bain’s leading experts on commercial excellence to take us to the cutting edge of investor relations.